PAREXEL CHAIRMAN AND CEO TO DELIVER KEYNOTE AT MASSBIO CRO/CMO SYMPOSIUM

February 23, 2012

Boston, MA, February 23, 2012PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Josef H. von Rickenbach, Chairman and Chief Executive Officer of PAREXEL, will deliver a keynote address at the inaugural Massachusetts Biotechnology Council (MassBio) CRO/CMO Symposium, to be held March 6, 2012 at Bentley University in Waltham, Massachusetts. The symposium, organized by the MassBio Contract Research Organization (CRO) and Contract Manufacturing Organization (CMO) Committee, will bring together experts from biopharmaceutical companies and service providers, as well as regulatory authorities, venture capitalist firms, government, and academia to address ways to accelerate drug development. The program features case studies of biopharmaceutical companies using external resources provided by CROs and CMOs.

Mr. von Rickenbach will address the opportunities the biotech industry has to drive greater efficiencies in their development efforts through a spectrum of proven operating practices and relationship models. He will draw on PAREXEL’s 30-year history working in a deeply collaborative way with biotech companies to help them achieve short- and long-term development and commercialization milestones, and realize significant value.

“While the biotech industry must find ways to navigate a challenging regulatory and commercial environment, it is well positioned, especially with the return of funding sources, to seize many opportunities for growth. Small and mid-sized biopharma companies own more than 60 percent of the industry’s intellectual property, and are developing novel compounds across key therapeutic areas,” said Mr. von Rickenbach. “I look forward to contributing to this important MassBio event and working with members of the CRO/CMO Committee to bring our expertise and experience together to ensure the innovative research of the vibrant biotech community more quickly reaches patients in need.”

Other major presentations during the symposium will be given by Karen N. Archdeacon, Compliance Officer, U.S. Food and Drug Administration (FDA) New England District, and Timothy Murray, Lieutenant Governor of Massachusetts, who will discuss job creation in the current economic climate. For more information about the symposium visit: http://www.massbio.org/

Offering flexible, strategic solutions, PAREXEL provides biotech companies with integrated product development consulting, including lifecycle management planning and execution, to help them make the right decisions about their potential development, regulatory, clinical and commercialization pathways.

Leveraging its worldwide resources and technology infrastructure, PAREXEL has conducted clinical development programs on a global scale for clients across a broad range of therapeutic areas. The Company’s vast investigator network, experience with various patient groups, and capacity to support innovative approaches to drug development can accelerate emerging and mid-size companies’ efforts to deliver new medical treatments to the patients who need them. PAREXEL is well positioned to combine leading eClinical solutions with proven clinical processes to deliver meaningful operational improvements.  For more information about the range of capabilities PAREXEL brings together to assist companies of all sizes, visit: http://www.PAREXEL.com/business-challenges/flexible-outsourcing-models/.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.  Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.  Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 52 countries around the world, and has approximately 11,300 employees. For more information about PAREXEL International visit www.PAREXEL.com.

 

BioFlash

Membership Deliverables

MassBio Membership gives you:

Purchasing power-MassBio negotiates a broad-based collection of services on behalf of member companies and passes the savings on to its members. 

Networking and professional development-MassBio organizes and executes numerous conferences, committee meetings, and networking events throughout the year.

MassBio Signature Events-Attend our Investors Forum, Innovator Roundtables, Pharma Days, our Golf Classic Fundraiser, Policy Leadership Breakfast, and many others.

Public policy & Advocacy-As the state's leading advocate for our life science super cluster, we fight for public policy initiatives and tax incentives in Massachusetts and Washington, D.C., that will enable biotechnology companies to do their best work.

Economic development-MassBio provides expert advice and guidance to help companies find suitable locations and resources as they move to and grow in the Bay State. We make Massachusetts a better place for your business.

Visibility/Resources-Members are listed on a searchable directory that includes a profile and link to the company's website. We highlight your company's latest news by posting to our MassBio member news page. In addition, members can post job openings on our website free!

Educational incentives-We promote education, workforce development and lifelong learning through the MassBioEd Foundation. The foundation customizes training programs for companies and educational institutions and promotes science in the classroom through BioTeach. MassBio members receive a discount on courses offered by the foundation.